Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

14. November 2005 04:03 ET | Quelle: Biolipox AB

Boehringer Ingelheim and Biolipox Sign Agreement on a New Class of Drugs to Treat Pain and Inflammation

STOCKHOLM, Sweden, Nov. 14, 2005 (PRIMEZONE) -- Boehringer Ingelheim GmbH and Biolipox announced today that they agreed to a worldwide exclusive research and license collaboration. The aim of the...
22. Februar 2005 02:51 ET | Quelle: Biolipox AB

Biolipox Reports Rapid Relief with NLA Nasal Spray in New Clinical Trial

STOCKHOLM, Sweden, Feb. 22, 2005 (PRIMEZONE) -- Biolipox, a Swedish research-intensive pharmaceutical company in respiratory and inflammatory diseases, announced today that it has successfully...
21. Februar 2005 03:06 ET | Quelle: Biolipox AB

Biolipox -- Year-end Report 2004

STOCKHOLM, Sweden, Feb. 21, 2005 (PRIMEZONE) -- Biolipox: Full-year 2004 -- Biolipox secure additional funding -- international venture capital firms invest EUR 30 million -- NLA Nasal...
17. Februar 2005 08:15 ET | Quelle: Biolipox AB

Biolipox Joins Top-Ranked EU Project

STOCKHOLM, Sweden, Feb. 17, 2005 (PRIMEZONE) -- Biolipox, a Swedish research-intensive pharmaceutical company in respiratory and inflammatory diseases, today announces that it has been selected to...
01. Juni 2004 03:57 ET | Quelle: Biolipox AB

Biolipox Announces Positive Results from Clinical Phase II Trial in Rhinitis

STOCKHOLM, Sweden, June 1, 2004 (PRIMEZONE) -- Biolipox, a research intensive pharmaceutical company targeting inflammation and respiratory diseases, today announced positive preliminary results from...